About this trial
Fibromyalgia (FM) is a chronic musculoskeletal pain disorder that afflicts up to 4% of the general population. The evaluation of pain mechanisms in FM has shown predominant central abnormalities and therefore has been designated as nociplastic pain syndrome. Rheumatoid arthritis (RA) is characterized by polyarthritis and pain from inflamed tissues, consistent with nociceptive pain. FM and RA patients may utilize overlapping pain mechanisms resulting in nociceptive and nociplastic pain.
Eligibility criteria
Qualifiers
Ages 18-70
Fulfills the 1990 and 2011 American College of Rheumatology Criteria for FM
Fulfills the 2010 ACR-EULAR classification criteria for RA
Healthy volunteers: No significant pain/fatigue/depression/anxiety.
Disqualifiers
Diabetes
Cancer
Advanced liver, kidney or cardiovascular disease
Neuropathic pain
Trial design
Treatments tested in this trial
- Not listed